Estimated impact of timely guidelines-based initiation of dual-combination anti-hypertensive therapy on long-term cardiovascular outcomes in a population of 1.4 million individuals.

Back

ESC Professional Premium Access

Estimated impact of timely guidelines-based initiation of dual-combination anti-hypertensive therapy on long-term cardiovascular outcomes in a population of 1.4 million individuals.

Session: Challenges in hypertension management

Topic: Pharmacotherapy

Speaker: Professor A. Coca (Barcelona, ES)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Professor Antonio Coca

University of Barcelona, Barcelona (Spain)

11 presentations

2 followers

4 more presentations in this session

State-of-the-art lecture on pharmacotherapy in hypertension

Speaker: Professor A. Pathak (Monaco, MC)

Access

Slides

Video

Effect of initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy on ambulatory blood pressure indices

Speaker: Doctor J. Nolde (Freiburg, DE)

Association of hydrochlorothiazide treatment compared to alternative diuretics with overall and skin cancer risk: a propensity-matched cohort study

Speaker: Doctor F. Goetzinger (Homburg, DE)

Evening anti-hypertensive dosing, blood pressure and cardiovascular events in hypertensive: Updated meta-analysis of 41 trials in 65,271 patients

Speaker: Doctor A. Sunjaya (London, GB)

Access the full session

Challenges in hypertension management

Speakers: Professor A. Coca, Professor A. Pathak, Doctor J. Nolde, Doctor F. Goetzinger, Doctor A. Sunjaya

Access

Video

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources